PHIO PHARMACEUTICALS CORP.

PHIO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Feb 6, 2026
4 Feb 6, 2026
4 Feb 6, 2026
4 Feb 6, 2026
4 Feb 6, 2026
4 Feb 6, 2026
8-K Jan 20, 2026 FORM 8-K
4 Jan 2, 2026
4 Dec 29, 2025
8-K Dec 23, 2025 FORM 8-K
SCHEDULE 13G/A Dec 11, 2025
424B3 Dec 4, 2025 FORM 424B3
EFFECT Dec 3, 2025
CORRESP Dec 1, 2025
8-K Nov 25, 2025 FORM 8-K
SCHEDULE 13G/A Nov 24, 2025
4 Nov 24, 2025
S-3 Nov 20, 2025 REGISTRATION STATEMENT
4 Nov 19, 2025
10-Q Nov 13, 2025 FORM 10-Q
8-K Nov 13, 2025 FORM 8-K
D Nov 12, 2025
SCHEDULE 13G/A Nov 12, 2025
SCHEDULE 13G Nov 10, 2025
SCHEDULE 13G/A Nov 7, 2025
← Newer Page 2 of 36 · 883 filings Older →